Alnylam Pharmaceuticals (ALNY) Q3 2026 Earnings

30JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
0.56
0.99
1.41
1.84

Details

Expected EPS
1.602614
Actual EPS
N/A
Surprise EPS
-1.6
Surprise Percent
+100%

Description

Alnylam Pharmaceuticals (ALNY) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts